- Home
- TNGX vs IPAR Comparison
TNGX vs IPAR Comparison
Compare TNGX & IPAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TNGX | IPAR |
|---|---|---|
| Founded | 2014 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.9B |
| IPO Year | 2020 | 1995 |
Fundamental Metrics
Financial Performance| Metric | TNGX | IPAR |
|---|---|---|
| Price | $20.23 | $90.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 5 |
| Target Price | $21.78 | ★ $116.60 |
| AVG Volume (30 Days) | ★ 2.5M | 202.2K |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 3.54% |
| EPS Growth | ★ 26.89 | 2.34 |
| EPS | N/A | ★ 1.35 |
| Revenue | $62,384,000.00 | ★ $1,317,700,000.00 |
| Revenue This Year | N/A | $3.86 |
| Revenue Next Year | N/A | $7.89 |
| P/E Ratio | ★ N/A | $65.84 |
| Revenue Growth | ★ 48.29 | 21.26 |
| 52 Week Low | $3.77 | $77.21 |
| 52 Week High | $28.41 | $142.50 |
Technical Indicators
Market Signals| Indicator | TNGX | IPAR |
|---|---|---|
| Relative Strength Index (RSI) | 42.30 | 49.01 |
| Support Level | $6.77 | $88.63 |
| Resistance Level | $22.01 | $98.36 |
| Average True Range (ATR) | 1.47 | 3.17 |
| MACD | -0.06 | -0.12 |
| Stochastic Oscillator | 6.95 | 48.07 |
Price Performance
Historical ComparisonAbout TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About IPAR Inter Parfums Inc.
Interparfums Inc operates in the fragrance business and produces and distributes a wide array of prestige fragrance and fragrance-related products. It sells its product under the brand which includes Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas and Van Cleef & Arpels. The company operates in two operating segments namely European based operations, SA, and United States based operations. The group sells its products to department stores, perfumeries, specialty stores, and domestic and international wholesalers and distributors.